| 4:00–8:00 PM | Registration |
| 6:00–8:00 PM | Welcome Mixer |
| 7:00–8:00 AM | Breakfast |
| 7:30–8:00 AM | Poster Setup |
| 7:45–5:00 PM | Poster Viewing |
| 8:00–8:10 AM | Welcome Remarks |
| 8:10–9:00 AM | Keynote Address |
| Dianne K. Newman, California Institute of Technology Rethinking AMR: How Heterogeneity in Metabolism Shapes Drug Resistance |
| 9:00–11:15 AM | Phage Biology and Therapy: Basic |
| Andrew Camilli, Tufts University Phage Cocktails for the Control of Cholera |
| Katrine L. Whiteson, University of California, Irvine Experimental Evolution of Gram Positive-Targeting Phages |
| Martha Clokie, University of Leicester Getting Bacteriophages Closer to Clinical Development |
| Kendal R Tinney, University of Oregon Short Talk: Impacts of Nasal Nutrients on Staphylococcus aureus Physiology and Adaptation to Bacteriophage |
| 9:30–9:50 AM | Coffee Break |
| 11:15–12:15 PM | Lunch |
| 12:00–2:30 PM | Poster Session 1 |
| 2:30–4:30 PM | Symposia Spotlight 1: From Bench to Bedside: An emerging Roadmap for New Therapies |
| Michael S Gilmore †, Harvard Medical School/Mass General Brigham Efagins Evolved Independently to Target the Enterococcal Cell Wall |
| Charlie Mo, University of Wisconsin-Madison Using Bacteriophages to Combat Drug Resistance and Virulence in Methicillin-Resistant Staphylococcus Aureus |
| Adeline Supandy, University of Pittsburgh Distinct Receptors Shape Phage Activity and Antimicrobial Resistance in Klebsiella spp. |
| Jee-Yon Lee, University of California at Davis Restoring Epithelial PPARγ Signaling Limits High-Fat Diet–Induced Susceptibility to Clostridioides difficile Infection |
| Drew Joel Schwartz, Washington University School of Medicine Using the Infant Gut Microbiome to Predict Sepsis and Tailor Antibiotics |
| Tahoura Samad, MIT Microbially-inspired Antidotes to Repurpose Toxic Compounds as Antimicrobials |
| Yash Sanjay Acharya †, JNCASR Breaching the Bacterial Cell Envelope: A Peptidomimetic Strategy to Overcome Metabolic Dormancy and Complicated Infections |
| Joshua Price, Harvard University (S)-crizotinib Drives Host-mediated Clearance of Intracellular Pathogens by Targeting Cholesterol Trafficking |
| 4:30–5:00 PM | Coffee Available |
| 5:00–7:00 PM | Phage Biology and Therapy: Applied |
| Daria Van Tyne, University of Pittsburgh Functional Genomics and Phage Therapy for Antibiotic-Resistant Bacterial Infections |
| Paul E. Turner, Yale University Leveraging Evolution to Fight Antibiotic Resistance with Phage Therapy |
| Susan M. Lehman, U.S. Food and Drug Administration An in vitro Preclinical Model of Phage Dosing for Localized Infections |
| Jennifer A. Schwartz, INTRALYTIX, INC. Phage Control of Pathogens in Food Processing, Medicine, and Environmental Settings |
| 7:00–8:00 PM | On Own for Dinner |
| 7:00–8:00 AM | Breakfast |
| 8:00–11:00 AM | Harnessing the Microbiome for Infection: Basic |
| Mariana X. Byndloss, Vanderbilt University Medical Center Host-Microbiota Metabolic Interactions during Infectious Gastroenteritis |
| Vanessa Sperandio, University of Wisconsin Microbiota Control of EHEC Pathogenesis |
| Bärbel Stecher, TUM School of Life Sciences Using Defined Microbiota Communities to Reveal Novel Insights into Colonization Resistance Against Salmonella |
| Katy Patras, Baylor College of Medicine Short Talk: Microbe-Based Strategies to Eradicate AMR Pathogens from the Vaginal Mucosa |
| Hallie Avalos, Vanderbilt Short Talk: Salmonella Typhimurium Relies on Vitamin C Utilization for Expansion During Intestinal Inflammation |
| Noah Lyons, NC State University Short Talk: Lachnospiraceae Bile Salt Hydrolases as Regulators of C. difficile Colonization Resistance and Pathogenesis |
| Apollo Stacy, Cleveland Clinic Short Talk: Dietary Nitrate Enhances Commensal-Mediated Antagonism of Oral Pathogens |
| 9:00–9:20 AM | Coffee Break |
| 11:00–1:00 PM | Poster Setup |
| 11:00–5:00 PM | On Own for Lunch |
| 1:00–10:00 PM | Poster Viewing |
| 3:00–4:30 PM | Career Roundtable |
| 4:30–5:00 PM | Coffee Available |
| 5:00–7:00 PM | Harnessing the Microbiome for Infection: Applied |
| Joseph P. Zackular, University of Pennsylvania Leveraging Ecology to Design New Therapeutic Strategies Against Clostridioides Difficile |
| Julie Segre, NIH/NHGRI Human Skin Microbiome: From Friends to Foes |
| Greg Medlock, Vedanta Biosciences Microbiome Therapeutics in the Age of Multi-Drug Resistant Pathogens |
| Amber Nguyen, University of Colorado Anschutz Medical Campus Short Talk: Bacteriocins from Staphylococcus hominis Protect Against Skin Pathogens |
| Jason Pizzini, Baylor College of Medicine Short Talk: Engineering the Gut Microbiome to Resist Multidrug-Resistant Pathogens |
| 7:00–8:00 PM | Social Hour with Dinner |
| 7:30–10:00 PM | Poster Session 2 |
| 7:00–8:00 AM | Breakfast |
| 8:00–11:00 AM | Leveraging Immunity to Combat Bacterial Infection: Basic |
| Kimberly Kline, University of Geneva Host-Pathogen Interactions in Mixed-Species Infections |
| Victor Torres, St. Jude Children's Research Hospital Impact of Nutrition on Host-Pathogen Interactions during ESKAPE Pathogen Infection |
| Raphael Valdivia, Duke University Akkermansia Mediated Control of Mucosal Immunity |
| Victor Choi, University of Oxford Short Talk: Antimicrobial-Loaded Ultrasound-Responsive Agents (AURAs) for Treatment of Wound Infections |
| Kai Yi E Lim, A*STAR Infectious Diseases Labs Short Talk: Siglec F- expressing Nasal Resident Myeloid Cells Protect Against Airway Infection by Hypervirulent Klebsiella pneumoniae |
| Rochelle Glover, Children's Hospital of Philadelphia Short Talk: mRNA-LNP Therapeutics for Clostridioides difficile Infection |
| Grant Norton, University of California San Diego Short Talk: Enterobactin Immunization Enables Precision Targeting of Adherent-Invasive Escherichia coli in a Murine Model of Colitis |
| 9:00–9:20 AM | Coffee Break |
| 11:00–5:00 PM | On Own for Lunch |
| 2:30–4:30 PM | Symposia Spotlight 2: Pulling the Right Lever - Target Discovery for Future Therapies and Prevention |
| Luke Joyce, University of Colorado Anschutz Medical Campus Group B Streptococcus Glycolipids Protect Against Immune Cell Clearance During Host-Pathogen Interactions |
| Lindsey R Burcham, University of Tennessee, Knoxville Iron Metabolism as a Key Regulator of Group B Streptococcus-Host Interactions |
| Kia Holt, University of Illinois College of Medicine The Acinetobacter baumannii Cyanide-Insensitive Oxidase is Required During Bloodstream Infection |
| Wendy Mok, UConn Health Nutrient Availability Modulates Staphylococcus aureus Repair and Resuscitation Following Antibiotic Treatment |
| Aanuoluwa Adekoya, University of Tennessee Knoxville Quantitative Analysis of Microbial Physiology within Human Chronic Wound Infection Models |
| Ffion Hammond †, University of Oxford Enrichment of Drug-Resistant Klebsiella Pneumoniae in the Gut Following Antibiotics Influences Subsequent Lung Challenge |
| Matt Barber, University of Oregon Adaptation of Staphylococcus Aureus to Host and Microbial Defenses |
| Ahmed M. M Moustafa, Children's Hospital of Philadelphia Enabling Precision Surveillance: A Genomics-Guided Approach to Rapidly Detect Circulating Pathogenic Lineages |
| 4:30–5:00 PM | Coffee Available |
| 5:00–7:00 PM | Leveraging Immunity to Combat Bacterial Infection: Applied |
| Molly A Ingersoll, Institut Cochin & Institut Pasteur Leveraging Mucosal Immunity in the Fight Against Recurrent Urinary Tract Infection |
| Victor Nizet, University of California, San Diego School of Medicine Novel Biomimetic Nanotherapies and Nanovaccines for AMR Pathogens |
| Andreas Peschel, Interfaculty Institute of Microbiology and Infection Medicine Teichoic Acids at the Staphylococcus-Host Interface |
| Ann Marie Stanley, AstraZeneca Monoclonal Antibodies to Prevent and Treat Bacterial Infections |
| 7:00–7:15 PM | Meeting Wrap-Up: Outcomes and Future Directions (Organizers) |
| 7:15–8:15 PM | Social Hour with Dinner |
| 8:00–11:00 PM | Cash Bar |
| 8:00–11:00 PM | Entertainment |
| 12:00–11:59 PM | Departure |